Health care providers relearn blood pressure measurement A typical doctor’s appointment starts off with a blood pressure check. It’s routine and critical in identifying silent killers like hyper tension or high blood pressure.
AMES, Iowa, April 24, 2012 (GLOBE NEWSWIRE) — NewLink Genetics Corporation (Nasdaq:NLNK – News) today announced that the United States Patent & Trademark Office (USPTO) has allowed broad claims to oral pharmaceutical compositions comprising 1-methyl-D-tryptophan (D-1MT) (US Serial No. 12/175,538) and also to oral pharmaceutical compositions comprising 1-methyl-DL-tryptophan (US Serial No
Newswise ATLANTA, Ga. Thomas R.
WASHINGTON–(BUSINESS WIRE)– The Biotechnology Industry Organization (BIO) announced today its selection of Representative Mike Rogers (R-MI) as Legislator of the Year for 2011-2012.
WASHINGTON–(BUSINESS WIRE)– The Biotechnology Industry Organization (BIO) announced today its selection of Senator Michael Enzi (R-WY) as a Legislator of the Year for 2011-2012. Senator Enzi receives the award in conjunction with todays BIO Legislative Day Fly-In reception
WASHINGTON–(BUSINESS WIRE)– The Biotechnology Industry Organization (BIO) announced today its selection of Senator Kay Hagan (D-NC) as Legislator of the Year for 2011-2012. Senator Hagan receives the award in conjunction with todays BIO Legislative Day Fly-In reception. As the sponsor of the TREAT Act, Senator Hagan has offered renewed hope to patients desperately in need of cures and breakthrough new medicines as well as a boost to our nations economy
WASHINGTON–(BUSINESS WIRE)– The Biotechnology Industry Organization (BIO) announced today its selection of Representative Allyson Schwartz (D-PA) as Legislator of the Year for 2011-2012. Representative Schwartz receives the award in conjunction with todays BIO Legislative Day Fly-In reception.
WASHINGTON–(BUSINESS WIRE)– The Biotechnology Industry Organization (BIO) announced today its selection of Representative Jack Kingston (R-GA) as Legislator of the Year for 2011-2012. Representative Kingston receives the award in conjunction with todays BIO Legislative Day Fly-In reception.
MARLBOROUGH, Mass.–(BUSINESS WIRE)– Advanced Cell Technology, Inc. (ACT; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today the dosing of the third patient in its Phase I/II trial for dry age-related macular degeneration (dry AMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs). The outpatient transplantation surgery was performed successfully, and the patient is recovering uneventfully
NEW YORK, April 10, 2012 /PRNewswire/ –IntelliCell BioSciences, Inc.(“Company”) (OTCQB: SVFC.PK) announced today that the Company has signed a technology licensing agreement with Stem Cells 21 of Thailand, http://www.StemCells21.com. Stem Cells 21 is led by Dr.
Scientists identify gene mutations that contribute to common childhood obesity the kind we normally chalk up to sloth and overeating which could someday lead to treatments for heavy kids. Image Source / Getty Images In the U.S., childhood obesity has more than tripled in the last 30 years and everyone from the food industry to parents to school lunch providers have been dished their fair share of blame. While environmental factors can have a profound effect on childrens weight, researchers also know that genes increase susceptibility to weight gain, and in a recent study, scientists found two gene variants that appear to play a large role in predisposing some children to obesity more than others.
MADEIRA BEACH, Fla., April 10, 2012 /PRNewswire/ –The Tampa Bay Lightning Foundation, the philanthropic arm of the Tampa Bay Lighting National Hockey League team, awarded Andrew P. Mandell, known internationally as Mr. Diabetes, $50,000 for his charity of choice, Defeat Diabetes Foundation
Public release date: 9-Apr-2012 [ | E-mail | Share ] Contact: Jill Scoggins jill.scoggins@louisville.edu 502-852-7461 University of Louisville LOUISVILLE, Ky. To paraphrase Yogi Berra: It’s dj vu all over again with a twist
MINNEAPOLIS–(BUSINESS WIRE)– The Cardiovascular Cell Therapy Research Network (CCTRN), a nationwide U.S.
Published on April 2, 2012 at 3:01 AM University of North Carolina at Chapel Hill researchers working as part of the International Cystic Fibrosis Consortium have discovered several regions of the genome that may predispose cystic fibrosis (CF) patients to develop an intestinal blockage while still in the uterus. A report of this international study appears online April 1, 2012 in the journal Nature Genetics. It was the work of the North America CF Gene Modifier Consortium, which brought together dozens of investigators from the United States, Canada, and from France, to identify genetic variations that could be linked with meconium ileus (MI), an intestinal obstruction that usually requires emergency surgery for treatment, and can result in a substantially increased rate of serious health problems.
Vanderbilt-Ingram Cancer Center researchers have identified a new population of intestinal stem cells that may hold clues to the origin of colorectal cancer. This new stem cell population, reported March 30 in the journal Cell, appears to be relatively quiescent (inactive) – in contrast to the recent discovery of intestinal stem cells that multiply rapidly – and is marked by a protein, Lrig1, that may act as a “brake” on cell growth and proliferation.
Public release date: 29-Mar-2012 [ | E-mail | Share ] Contact: Melissa Marino melissa.marino@vanderbilt.edu 615-322-4747 Vanderbilt University Medical Center Vanderbilt-Ingram Cancer Center researchers have identified a new population of intestinal stem cells that may hold clues to the origin of colorectal cancer. This new stem cell population, reported March 30 in the journal Cell, appears to be relatively quiescent (inactive) in contrast to the recent discovery of intestinal stem cells that multiply rapidly and is marked by a protein, Lrig1, that may act as a “brake” on cell growth and proliferation
Posted: Thursday, March 29, 2012 2:00 pm | Updated: 11:39 am, Thu Mar 29, 2012. New Iberia veterinarians agree that six-month heartworm preventative injections are the way to go in stopping the disease, but differ on why
LOS ANGELES, March 28, 2012 /PRNewswire/ –Diabetes has become an epidemic in the United States, with the number of cases tripling over the last three decades. Most of those cases are Type 2 diabetes, which is linked to obesity and can lead to serious medical issues that range from heart disease to renal failure, blindness, and more
–Trial that aims to address the leading cause of blindness in people with type 1 diabetes and type 2 diabetes being led by Johns Hopkins investigators– iDEAL Phase II Study Update VANCOUVER , March 28, 2012 /CNW/ – iCo Therapeutics (TSX-V: ICO.V – News), a Vancouver-based drug reprofiling company and JDRF, the largest charitable funder of type 1 Diabetes (T1D) research have joined forces to investigate a potential new treatment for one of the most common complications of diabetes, diabetic macular edema (DME).